NVCR logo

NovoCure Limited (NVCR) Cash from investing

annual CFI:

-$140.24M-$324.39M(-176.16%)
December 31, 2024

Summary

  • As of today (May 31, 2025), NVCR annual cash flow from investing activities is -$140.24 million, with the most recent change of -$324.39 million (-176.16%) on December 31, 2024.
  • During the last 3 years, NVCR annual CFI has risen by +$4.59 million (+3.17%).
  • NVCR annual CFI is now -176.16% below its all-time high of $184.15 million, reached on December 31, 2023.

Performance

NVCR Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

quarterly CFI:

-$6.47M+$15.74M(+70.86%)
March 31, 2025

Summary

  • As of today (May 31, 2025), NVCR quarterly cash flow from investing activities is -$6.47 million, with the most recent change of +$15.74 million (+70.86%) on March 31, 2025.
  • Over the past year, NVCR quarterly CFI has dropped by -$252.69 million (-102.63%).
  • NVCR quarterly CFI is now -102.14% below its all-time high of $302.70 million, reached on September 30, 2021.

Performance

NVCR quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

TTM CFI:

-$392.93M-$252.69M(-180.18%)
March 31, 2025

Summary

  • As of today (May 31, 2025), NVCR TTM cash flow from investing activities is -$392.93 million, with the most recent change of -$252.69 million (-180.18%) on March 31, 2025.
  • Over the past year, NVCR TTM CFI has dropped by -$741.01 million (-212.89%).
  • NVCR TTM CFI is now -212.89% below its all-time high of $348.08 million, reached on March 31, 2024.

Performance

NVCR TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NVCR Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-176.2%-102.6%-212.9%
3 y3 years+3.2%+62.8%-81.6%
5 y5 years-171.4%-108.0%-630.5%

NVCR Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-176.2%+3.2%-102.6%+98.3%-212.9%+23.1%
5 y5-year-176.2%+70.3%-102.1%+99.0%-212.9%+23.1%
alltimeall time-176.2%+70.3%-102.1%+99.0%-212.9%+23.1%

NVCR Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$6.47M(-70.9%)
-$392.93M(+180.2%)
Dec 2024
-$140.24M(-176.2%)
-$22.21M(-317.9%)
-$140.24M(+618.0%)
Sep 2024
-
$10.19M(-102.7%)
-$19.53M(+56.7%)
Jun 2024
-
-$374.44M(-252.1%)
-$12.47M(-103.6%)
Mar 2024
-
$246.22M(+150.0%)
$348.08M(+89.0%)
Dec 2023
$184.15M(-231.6%)
$98.50M(+470.7%)
$184.15M(-534.2%)
Sep 2023
-
$17.26M(-224.2%)
-$42.41M(-79.8%)
Jun 2023
-
-$13.90M(-116.9%)
-$209.91M(+421.4%)
Mar 2023
-
$82.29M(-164.3%)
-$40.26M(-71.2%)
Dec 2022
-$139.96M(-3.4%)
-$128.06M(-14.8%)
-$139.96M(-72.6%)
Sep 2022
-
-$150.24M(-196.5%)
-$510.99M(+780.4%)
Jun 2022
-
$155.76M(-994.6%)
-$58.04M(-73.2%)
Mar 2022
-
-$17.41M(-96.5%)
-$216.41M(+49.4%)
Dec 2021
-$144.83M(-69.4%)
-$499.09M(-264.9%)
-$144.83M(-44.2%)
Sep 2021
-
$302.70M(<-9900.0%)
-$259.38M(-37.5%)
Jun 2021
-
-$2.62M(-104.8%)
-$414.87M(-0.2%)
Mar 2021
-
$54.17M(-108.8%)
-$415.56M(-12.1%)
Dec 2020
-$472.85M(+815.2%)
-$613.64M(-516.8%)
-$472.85M(-602.8%)
Sep 2020
-
$147.22M(-4541.0%)
$94.03M(-269.9%)
Jun 2020
-
-$3.31M(+6.5%)
-$55.36M(+2.9%)
Mar 2020
-
-$3.11M(-93.3%)
-$53.79M(+4.1%)
DateAnnualQuarterlyTTM
Dec 2019
-$51.67M(+840.6%)
-$46.76M(+2050.7%)
-$51.67M(+671.1%)
Sep 2019
-
-$2.17M(+24.4%)
-$6.70M(+21.1%)
Jun 2019
-
-$1.75M(+76.7%)
-$5.53M(+19.6%)
Mar 2019
-
-$989.00K(-44.7%)
-$4.63M(-15.8%)
Dec 2018
-$5.49M(-163.7%)
-$1.79M(+78.0%)
-$5.49M(-2.8%)
Sep 2018
-
-$1.00M(+19.4%)
-$5.65M(-11.7%)
Jun 2018
-
-$842.00K(-54.7%)
-$6.40M(+4.2%)
Mar 2018
-
-$1.86M(-4.6%)
-$6.14M(-171.2%)
Dec 2017
$8.63M(-33.6%)
-$1.95M(+11.0%)
$8.63M(+20.4%)
Sep 2017
-
-$1.75M(+199.1%)
$7.16M(+59.1%)
Jun 2017
-
-$586.00K(-104.5%)
$4.50M(-393.2%)
Mar 2017
-
$12.91M(-478.7%)
-$1.54M(-111.8%)
Dec 2016
$13.00M(-111.3%)
-$3.41M(-22.7%)
$13.00M(-111.9%)
Sep 2016
-
-$4.41M(-33.4%)
-$109.63M(+40.8%)
Jun 2016
-
-$6.63M(-124.1%)
-$77.85M(-28.7%)
Mar 2016
-
$27.45M(-121.8%)
-$109.13M(-5.3%)
Dec 2015
-$115.30M(+149.7%)
-$126.04M(-560.6%)
-$115.30M(-1173.2%)
Sep 2015
-
$27.36M(-172.2%)
$10.74M(-164.6%)
Jun 2015
-
-$37.91M(-278.1%)
-$16.62M(-178.1%)
Mar 2015
-
$21.28M
$21.28M
Dec 2014
-$46.18M(-544.0%)
-
-
Dec 2013
$10.40M
-
-

FAQ

  • What is NovoCure Limited annual cash flow from investing activities?
  • What is the all time high annual CFI for NovoCure Limited?
  • What is NovoCure Limited annual CFI year-on-year change?
  • What is NovoCure Limited quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for NovoCure Limited?
  • What is NovoCure Limited quarterly CFI year-on-year change?
  • What is NovoCure Limited TTM cash flow from investing activities?
  • What is the all time high TTM CFI for NovoCure Limited?
  • What is NovoCure Limited TTM CFI year-on-year change?

What is NovoCure Limited annual cash flow from investing activities?

The current annual CFI of NVCR is -$140.24M

What is the all time high annual CFI for NovoCure Limited?

NovoCure Limited all-time high annual cash flow from investing activities is $184.15M

What is NovoCure Limited annual CFI year-on-year change?

Over the past year, NVCR annual cash flow from investing activities has changed by -$324.39M (-176.16%)

What is NovoCure Limited quarterly cash flow from investing activities?

The current quarterly CFI of NVCR is -$6.47M

What is the all time high quarterly CFI for NovoCure Limited?

NovoCure Limited all-time high quarterly cash flow from investing activities is $302.70M

What is NovoCure Limited quarterly CFI year-on-year change?

Over the past year, NVCR quarterly cash flow from investing activities has changed by -$252.69M (-102.63%)

What is NovoCure Limited TTM cash flow from investing activities?

The current TTM CFI of NVCR is -$392.93M

What is the all time high TTM CFI for NovoCure Limited?

NovoCure Limited all-time high TTM cash flow from investing activities is $348.08M

What is NovoCure Limited TTM CFI year-on-year change?

Over the past year, NVCR TTM cash flow from investing activities has changed by -$741.01M (-212.89%)
On this page